Management of Posterior-Inferior STEMI
For posterior-inferior myocardial infarction, immediate reperfusion with primary PCI is the priority treatment, followed by dual antiplatelet therapy (aspirin plus ticagrelor or prasugrel) for 12 months, high-intensity statin therapy, ACE inhibitor, beta-blocker (if LVEF <40% or heart failure), and cardiac rehabilitation.
Acute Phase Management
Reperfusion Strategy
The cornerstone of acute management is urgent reperfusion therapy within 12 hours of symptom onset 1. The approach depends on timing:
- Primary PCI is the preferred strategy if it can be performed within 120 minutes of STEMI diagnosis 1
- Transfer directly to the catheterization laboratory, bypassing the emergency department 1
- If primary PCI cannot be achieved within this timeframe, initiate fibrinolytic therapy immediately (within 10 minutes of diagnosis), preferably with fibrin-specific agents like tenecteplase, alteplase, or reteplase 1
Critical caveat for inferior-posterior MI: Watch for high-risk features on ECG including left precordial ST-depression, complete AV block, and right precordial ST-elevation (indicating RV involvement) 2. These patients have significantly higher mortality and benefit most from aggressive reperfusion.
Antithrombotic Therapy During PCI
Administer immediately 1:
- Aspirin (oral or IV if unable to swallow) as soon as possible
- Potent P2Y12 inhibitor: Ticagrelor or prasugrel (preferred over clopidogrel) given before or at the time of PCI
- Unfractionated heparin during the procedure (enoxaparin or bivalirudin are alternatives)
- Avoid fondaparinux for primary PCI 1
If Fibrinolysis is Used
When PCI is not immediately available 1:
- Enoxaparin IV followed by subcutaneous (preferred over UFH) 1
- Aspirin plus clopidogrel (not prasugrel/ticagrelor with fibrinolysis)
- Transfer to PCI-capable center immediately after fibrinolysis 1
- Perform angiography and PCI of the infarct-related artery between 2-24 hours after successful fibrinolysis 1
- Rescue PCI immediately if fibrinolysis fails (<50% ST-resolution at 60-90 minutes) or if hemodynamic/electrical instability develops 1
Monitoring for Complications
Perform routine echocardiography during hospitalization to assess LV and RV function, detect mechanical complications (particularly papillary muscle rupture in inferior-posterior MI), and exclude LV thrombus 1. Papillary muscle rupture is a rare but catastrophic complication that occurs predominantly with inferior-posterior infarctions 3, presenting with acute pulmonary edema and refractory shock—maintain high suspicion if these develop.
Secondary Prevention (Long-term Management)
Antiplatelet Therapy
Dual antiplatelet therapy (DAPT) for 12 months is mandatory 1:
- Aspirin 75-100 mg daily indefinitely 1
- Plus ticagrelor or prasugrel (or clopidogrel if unavailable/contraindicated) for 12 months 1
- Add PPI if high gastrointestinal bleeding risk 1
Non-adherence to DAPT is associated with 21% increased mortality risk 4, making this a critical intervention.
Lipid Management
Start high-intensity statin therapy immediately and continue long-term 1:
- Target LDL-C <1.8 mmol/L (70 mg/dL) or at least 50% reduction if baseline LDL-C is 1.8-3.5 mmol/L 1
- Non-adherence to statin therapy increases mortality by 16% 4
RAAS Inhibition
ACE inhibitor within first 24 hours for 1, 5:
- Anterior MI location
- Heart failure or LVEF ≤40%
- Diabetes mellitus
- Consider for all STEMI patients without contraindications 5
ARB (preferably valsartan) if ACE inhibitor intolerant 1, 5
Aldosterone antagonist (MRA) if 1:
- LVEF <40% AND
- Already on ACE inhibitor and beta-blocker AND
- Symptomatic heart failure or diabetes
- No severe renal failure or hyperkalemia
Beta-Blocker Therapy
Oral beta-blocker is indicated if 1:
- Heart failure present
- LVEF <40%
Avoid IV beta-blockers in patients with hypotension, acute heart failure, AV block, or severe bradycardia 1, 5. The COMMIT trial showed early IV beta-blockers increase cardiogenic shock risk, especially in elderly patients (>70 years), those with systolic BP <120 mmHg, or heart rate >110 bpm 5.
Cardiac Rehabilitation
Enrollment in cardiac rehabilitation program is mandatory 1. Only 13.4% of patients adhere to recommended CR programs, yet adherence reduces mortality by 27% 4. This includes:
- Structured exercise training
- Smoking cessation with pharmacotherapy (nicotine replacement, varenicline, or bupropion) and behavioral support 1
- Dietary counseling
- Psychosocial intervention 6
Blood Pressure Management
While specific targets for post-MI patients remain debated 7, BP control is achieved through the medications above (ACE inhibitor, beta-blocker, MRA). Balance afterload reduction against the theoretical J-curve phenomenon, particularly avoiding excessive diastolic BP lowering in the early post-MI period.
Key Clinical Pitfalls
Missing posterior MI on ECG: Look for isolated ST-depression in anterior leads (V1-V3)—this represents reciprocal changes from posterior ST-elevation. Consider posterior leads (V7-V9) 1
RV involvement: Right precordial ST-elevation indicates RV infarction, requiring careful fluid management and avoidance of nitrates/morphine which can precipitate hypotension
Premature discontinuation of DAPT: The 12-month duration is evidence-based and critical—only excessive bleeding risk justifies early cessation 1
Delaying ACE inhibitor: Should be started within 24 hours unless contraindicated 1, 5
Inadequate statin intensity: Use high-intensity statins from the start, not moderate-dose 1